Bracket Announces the Newest Release of Rater Station
SAN FRANCISCO, Jan. 11, 2016 /PRNewswire/ -- Bracket, a leading clinical trial specialty services provider, has released version 4.0 of Rater Stationâ , an innovative Electronic Clinical Outcomes Assessment (eCOA) tool designed to improve performance and outcomes in clinical trials. The Rater Stationâ platform has been used extensively in Central Nervous System clinical trials, and version 4.0 is currently being used in two clinical trials that are actively recruiting.
Precision at Every Step
Bracket's Rater Stationâ , an enhanced type of electronic Clinician-Reported Outcome (eClinRO), uniquely features intelligent design that provides added clinical value and quality control. Rater Stationâ has been used in dozens of pivotal worldwide studies, and is a core component of Bracket's eCOA platform.
"The Rater Stationâ intelligent question design improves data quality while reducing investigator and patient burden. This release incorporates the feedback of more than 20 stakeholders, and is our most usable and secure version yet," stated David G. Daniel, MD, Chief Medical Officer for Bracket.
In addition to a completely re-designed user interface, this release incorporates several critical improvements which enable sites to conduct their clinical interviews more accurately. These improvements include:
Persistent Auto-Save, loss of power, user error, or system malfunction will never mean lost data.
Advanced authentication and user management features, allowing study sponsors more granular control of which site personnel can access data.
A new and improved Question Library, allows for advanced customization for each scale and questionnaire programmed into the platform.
Improved clinical edit checks, designed to reduce errors and minimize burdensome data corrections.
New workflow that streamlines subject visits for study personnel.
"The reliable application of outcome measures is crucial to conducting high quality trials. Innovative technology can help with this issue. However, it is crucial that when introducing new technology, we take care to make patient assessment easier for site staff. Technologies such as Rater Stationâ can help improve trial conduct and, through intuitive design, aid patient assessment," stated John Harrison, PhD, Associate Professor Alzheimer Center at the VU University Medical Center, Amsterdam, and a member of Bracket's Scientific Advisory Board.
About Bracket
Bracket, with seven offices and more than 500 employees worldwide, is a specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
